{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-009976","form_type":"8-K","ticker":"HRGN","cik":"0001563665","company_name":"Harvard Apparatus Regenerative Technology, Inc.","filed_at":"2022-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.213961+00:00","generated_at":"2026-06-25T02:20:56.174322+00:00","sec_items":["3.02","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Biostage issues $4M Series E Convertible Preferred to Harvard Bioscience to satisfy indemnification","bullets":["Issued 4,000 shares of Series E Preferred at $1,000/share to HBIO on June 10, 2022, to settle $4M indemnification obligations.","8% annual dividend payable quarterly in additional Series E shares; ranks senior to common stock.","Mandatory conversion upon NASDAQ uplisting, IPO, or $4M+ private placement; optional conversion based on 60-day VWAP.","Consent rights restrict debt over $500K, certain related-party transactions, and issuance of senior or pari passu securities.","Beneficial ownership limitation capped at 9.99% on conversion; limited piggyback registration rights if Rule 144 unavailable."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-009976","json":"https://secwatch.observer/filing/0001558370-22-009976.json","markdown":"https://secwatch.observer/filing/0001558370-22-009976.md","text":"https://secwatch.observer/filing/0001558370-22-009976.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563665/000155837022009976/0001558370-22-009976-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563665/000155837022009976/tmb-20220610x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:20:56.174322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}